TYRA: SEC Form 8-K filed by Tyra Biosciences Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for TYRA
Across the 19 sessions after earlier TYRA headlines, the stock closed higher 10 times and lower 9 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TYRA | SPY |
|---|---|---|---|
| Sep 14, 2026 | Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants | +13.8% | -0.4% |
| Sep 9, 2026 | Tyra Biosciences Reports Initial Phase 2 SURF302 Results Supporting the First Potential Oral Innovation in LG IR NMIBC with Dabogratiniband 1 other headline that session | -17.7% | -0.5% |
| Sep 4, 2026 | Tyra Biosciences to Host Conference Call on Initial Results of Oral Dabogratinib from the SURF302 Phase 2 Study for IR NMIBC on September 9, 2026 | +15.2% | -0.4% |
| Aug 5, 2026 | Tyra Biosciences Reports Second Quarter 2026 Financial Results and Recent Highlights | -21.0% | -0.2% |
| May 21, 2026 | TYRA BIOSCIENCES AND BCAN ESTABLISH MAY 21 AS UPPER TRACT UROTHELIAL CANCER (UTUC) AWARENESS DAY | -1.1% | +0.2% |
| May 19, 2026 | Wolfe Research initiated coverage on Tyra Biosciences | -5.3% | -0.7% |
Keep researching TYRA
- What is Form 8-K?The SEC "current report" a public company files to disclose material events, generally within four business days of the event.
- Form 8-K explainedWhat a Form 8-K is, when it is due, and what each key item number means, from 1.01 material agreements and 2.02 earnings to 4.02 restatements and 5.02 executive changes.
- TYRA insider tradesEvery buy and sale reported by Tyra Biosciences Inc. officers, directors and large holders.
- TYRA earnings historyPast Tyra Biosciences Inc. earnings releases, newest first.
- TYRA financial statementsRevenue, profit, cash flow and balance sheet from Tyra Biosciences Inc.'s SEC filings.
Quantisnow market dataNASDAQ
TYRA
Tyra Biosciences Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2021
Get push alerts for TYRA
Full TYRA profile on Quantisnow Follow TYRA and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time